Lincoln Pharmaceuticals Limited (NSE:LINCOLN)
550.85
-54.70 (-9.03%)
May 22, 2025, 3:30 PM IST
Lincoln Pharmaceuticals Market Cap
Lincoln Pharmaceuticals has a market cap or net worth of 12.06 billion as of May 22, 2025. Its market cap has increased by 0.99% in one year.
Market Cap
12.06B
Enterprise Value
10.10B
Revenue
5.98B
Ranking
n/a
PE Ratio
13.50
Stock Price
550.85
Market Cap Chart
Since October 21, 2004, Lincoln Pharmaceuticals's market cap has increased from 138.90M to 12.06B, an increase of 8,584.30%. That is a compound annual growth rate of 24.20%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sun Pharmaceutical Industries | 4,097.58B |
Divi's Laboratories | 1,712.94B |
Cipla | 1,174.63B |
Mankind Pharma | 1,051.75B |
Apollo Hospitals Enterprise | 993.84B |
Zydus Lifesciences | 888.81B |
Aurobindo Pharma | 692.20B |
Alkem Laboratories | 628.79B |